Cyber Resilience

CVE-2025-40724

Medium

Published: 16 July 2025

Published
16 July 2025
Modified
15 April 2026
KEV Added
Patch
CVSS Score v4 5.1 CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
EPSS Score 0.0027 50.8th percentile
Risk Priority 10 60% EPSS · 20% KEV · 20% CVSS

Summary

CVE-2025-40724 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Incibe (inferred from references). Its CVSS base score is 5.1 (Medium).

Operationally, ranked in the top 49.2% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog.

EU & UK References

Vulnerability details

Stored Cross-Site Scripting (XSS) vulnerability in Pharmacy POS PHP Script. This vulnerability allows an attacker to execute JavaScript code in the victim's browser by sending the victim a malicious URL using the u_medicine_name parameter in /edit_medicine.php. This vulnerability can be…

more

exploited to steal sensitive user data such as session cookies or to perform actions on behalf of the user.

CWE(s)

Related Threats

No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.

Affected Assets

Incibe
inferred from references and description; NVD did not file a CPE for this CVE

Mitigating Controls

Likely Mitigating Controls AI

Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.

addresses: CWE-79

Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.

addresses: CWE-79

Validates web inputs to reject script-related content that could produce XSS.

addresses: CWE-79

Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.

References